Top Markets
#1 MowCat MowCat +49.25%
#2 Bitway Bitway +26.57%
#3 Velvet Velvet +25.14%
#4 aPriori aPriori +22.18%
#5 Fake World Assets Fake World Assets +21.99%
#6 OVERTAKE OVERTAKE +19.42%
#7 Derive Derive +16.17%
#8 Verus Coin Verus Coin +15.91%
#9 Audiera Audiera +15.17%
#10 TROLL TROLL +15.14%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Hainan Poly Pharm. Co., Ltd Hainan Poly Pharm. Co., Ltd

Hainan Poly Pharm. Co., Ltd

300630
Clasificación en acciones #34414
Hainan Poly Pharm. Co., Ltd. operates as a pharmaceutical enterprise in China,... Hainan Poly Pharm. Co., Ltd. operates as a pharmaceutical enterprise in China, engaging in the full spectrum of activities from research and development to the production and distribution of medicinal products. The company supplies Active Pharmaceutical Ingredients (APIs) and also manufactures a diverse array of finished drug formulations. These therapeutic preparations cater to various medical needs, including anti-allergy, non-steroidal anti-inflammatory, antibiotic, and digestive conditions. Key products within their portfolio include desloratadine preparations for anti-allergy treatment, diclofenac formulations for anti-inflammatory relief, azithromycin for injection and clarithromycin preparations as antibiotics, and trimebutine maleate for digestive health. Established in 1992, the company is headquartered in Haikou, China.
Precio por acción
$0.12353728
Última sincronización: 2025-05-22
Capitalización bursátil
$5.65M
Cambio (1 día)
-4.21%
Cambio (1 año)
0.00%
País
CN
Comercio Hainan Poly Pharm. Co., Ltd (300630)

Categoría

Healthcare
Ganancias de Hainan Poly Pharm. Co., Ltd (300630)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Hainan Poly Pharm. Co., Ltd, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Hainan Poly Pharm. Co., Ltd desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN